| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/04/2003 | US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders |
| 09/04/2003 | US20030166886 Candida albicans proteins associated with virulence and hyphal formation and uses thereof |
| 09/04/2003 | US20030166877 Reducing the immunogenicity of fusion proteins |
| 09/04/2003 | US20030166875 Fibroblast growth factor homologous factor-2 and methods of use |
| 09/04/2003 | US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration |
| 09/04/2003 | US20030166864 Controlling immunology; antiinflammatory agents |
| 09/04/2003 | US20030166856 A set of open reading frames encoded with the template as the plus strand of the proviral DNA, and located in the region of HIV-1 long terminal repeat, and the genes encode a set of antisense proteins |
| 09/04/2003 | US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound |
| 09/04/2003 | US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
| 09/04/2003 | US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin |
| 09/04/2003 | US20030166841 Escherichia coli secreted protein b |
| 09/04/2003 | US20030166832 Methods and compositions for impairing multiplication of HIV-1 |
| 09/04/2003 | US20030166599 Uses of tgap7 for the modulation of leucocyte activation |
| 09/04/2003 | US20030166590 Microsomal triglyceride transfer protein |
| 09/04/2003 | US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation |
| 09/04/2003 | US20030166568 Organic compounds |
| 09/04/2003 | US20030166562 Treatment for asthma or allergies |
| 09/04/2003 | US20030166557 SEMA3B inhibits tumor growth and induces apoptosis in cancer cells |
| 09/04/2003 | US20030166556 Immunoregulator |
| 09/04/2003 | US20030166555 Methods and compositions for regulating memory consolidation |
| 09/04/2003 | US20030166554 Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| 09/04/2003 | US20030166551 For inhibiting expression of adhesion molecules in vascular endothelial cells comprising adipose tissue-specific secretory factor |
| 09/04/2003 | US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions. |
| 09/04/2003 | US20030166533 Genes for male accessory gland proteins in Drosophila melanogaster |
| 09/04/2003 | US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation. |
| 09/04/2003 | US20030166531 Methods for modulating an immune response comprising contacting a cell with an agent that modulates the interaction between CTLA4 and PP2AA via modulating the lysine rich motif of CTLA4. The invention further provides methods |
| 09/04/2003 | US20030166526 Novel gene (designated 158P1H4) and its encoded protein are described. While 158P1H4 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1H4 |
| 09/04/2003 | US20030166519 Agents that modulate growth regulation and cell differentiation. More particularly, the present invention relates to novel OKL38 polypeptides that modulate growth regulation and differentiation of mammary epithelial cells |
| 09/04/2003 | US20030166518 Characterization of allergens using recombinant fusion protein in an enzyme-linked immunosorbent (ELISA) assay. Also disclosed are methods for determining allergen sensitivity and methods for immunotherapy using the ELISA of the present |
| 09/04/2003 | US20030166503 Method for recognizing and determining GnRH receptors and use of GnRH agonist for decreasing the replication of malignant cells bearing GnRH receptors of tumors orginating in the nervous system and/or meninges and/or of Kaposi sarcoma |
| 09/04/2003 | US20030166502 Methods for selectively regulating survival and proliferation in a T cell by modulating the activity of certain amino acid motifs in the CD28 protein. |
| 09/04/2003 | US20030166501 Mucin-related tumor marker |
| 09/04/2003 | US20030166306 Method and device for recognition of a target molecule by means of molecularly imprinted polymers |
| 09/04/2003 | US20030166303 Novel screening method for molecular antagonist using flow-cytometry |
| 09/04/2003 | US20030166302 Allowing an antibody or an antibody complex which reacts specifically to the antigenic substance and binds to the antigenic substance to give a selective agglutination of the insoluble carrier particles |
| 09/04/2003 | US20030166301 Plurality of immobilized protein binding groups are immobilized such that the tertiary structure of the protein in each immobilized binding group permits specific binding to a molecule that is bound by the protein; and a marker molecule |
| 09/04/2003 | US20030166300 Growth-related inflammatory and immune response protein |
| 09/04/2003 | US20030166295 Measuring a detectable substance by using a reaction system including a formation reaction of the detectable substance having quantitative correlation with the analyte, based on a chemical reaction of analyte in a sample |
| 09/04/2003 | US20030166293 Secretion-monitoring article |
| 09/04/2003 | US20030166291 A pad is impregnated with a reagent (suflonated polysacchride) in fluid sample and is effective to entrap precipitated low density lipoprotein within the reagent pad |
| 09/04/2003 | US20030166290 Low formaldehyde producing blood diluent |
| 09/04/2003 | US20030166279 Minicell-based transfection |
| 09/04/2003 | US20030166264 Drug and alcohol assay assembly |
| 09/04/2003 | US20030166262 Apparatus and method for the manipulation and testing of molecules, and in particular of DNA |
| 09/04/2003 | US20030166261 Joining biological molecule to the glass surface, first treating the glass with a silane compound, coupling the end groups to form isocyanate group; estrogen receptor analysis for breast cancer, immunocytochemical assay |
| 09/04/2003 | US20030166259 Testing bodily fluids, particular saliva; immunoassay tests, clinical analysis |
| 09/04/2003 | US20030166258 Saccharomyces cerevisiae yeast strain with functional expression of a glut transporter |
| 09/04/2003 | US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 09/04/2003 | US20030166245 For preparing reagents for use in detecting molecules which affect formation of actin cytoskeleton; drug screening |
| 09/04/2003 | US20030166240 DNA & protein binding miniature proteins |
| 09/04/2003 | US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/04/2003 | US20030166232 PARG, a GTPase activating protein which interacts with PTPL1 |
| 09/04/2003 | US20030166228 Anti-interferon-alpha antibodies |
| 09/04/2003 | US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells |
| 09/04/2003 | US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK) |
| 09/04/2003 | US20030166193 Suppressors of death domains |
| 09/04/2003 | US20030166192 Nucleic acid encoding a converting enzyme (pseudo-ICE) that has specific binding to pro-caspase or RICK protein and stimulates necrosis factor-kappa B activation; use in modulating apoptosis or inflammation |
| 09/04/2003 | US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases |
| 09/04/2003 | US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/04/2003 | US20030166183 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 09/04/2003 | US20030166181 Controlled electroporation and mass transfer across cell membranes |
| 09/04/2003 | US20030166167 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds |
| 09/04/2003 | US20030166164 IL-17 like molecules and uses thereof |
| 09/04/2003 | US20030166163 Immunocytokines with modulated selectivity |
| 09/04/2003 | US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/04/2003 | US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening |
| 09/04/2003 | US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2003 | US20030166148 Transmembrane receptors, more particularly to a human G protein- coupled receptor for which the endogenous ligand is unknown ("orphan GPCR receptors"), and most particularly to mutated (non-endogenous) versions of the human GPCRs for |
| 09/04/2003 | US20030166141 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/04/2003 | US20030166137 Mammalian sweet and amino acid heterodimeric taste receptors |
| 09/04/2003 | US20030166132 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166102 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166101 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166100 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166099 Micelles comprising transmembrane polypeptides and expression vectors for use as drug screeening, gene transfer and diagnostic tools |
| 09/04/2003 | US20030166098 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases |
| 09/04/2003 | US20030166096 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166095 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166094 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166093 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166092 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166091 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166090 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166089 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166088 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166087 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166086 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166085 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166084 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166083 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166082 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166081 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166080 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166079 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166078 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166077 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166076 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |